Market Overview:
The global C-X-C chemokine receptor type 1 market is expected to grow at a CAGR of XX% during the forecast period from 2018 to 2030. The market growth can be attributed to the increasing prevalence of chronic diseases, rising geriatric population, and technological advancements in the field of medical devices. Based on type, the global C-X-C chemokine receptor type 1 market is segmented into DF-2755A, PAC-G31P, Reparixin, SX-576 and others. DF -2755A held a dominant share in 2017 and is projected to maintain its dominance during the forecast period. Based on application, the global C -X -C chemokine receptor type 1 market is segmented into inflammation , lung cancer , melanoma , postoperative pain and others . Postoperative pain held a dominant share in 2017 and is projected to maintain its dominance during the forecast period .
Product Definition:
The C-X-C chemokine receptor type 1 (CXCR1) is a G protein-coupled receptor that binds to CXC chemokines. The receptor is expressed on cells of the myeloid lineage, including neutrophils, monocytes, and macrophages. It has also been found on some epithelial cells and endothelial cells.
DF-2755A:
DF-2755A is a selective, high affinity, and competitive inhibitor of CXCR1. It has been studied in phase II clinical trials for the treatment of various cancers such as Non-small Cell Lung Cancer (NSCLC), triple-negative breast cancer, and metastatic melanoma. The compound has also shown efficacy in Phase I/II clinical studies for the treatment of Rheumatoid Arthritis (RA) and psoriasis.
PAC-G31P:
PAC-G31P is a PAC (plasminogen activator) ligand 31-kDa protein. It is also known as Surgical Plasminogen Activator Inhibitor or Serine (PAI) and it functions as an inhibitor of the fibrinolytic process by competing with r-tPA for binding to its receptor on blood vessels.
Application Insights:
The inflammation segment dominated the global market in terms of revenue generation in 2017. The growth can be attributed to the usage of CXCR1 and CXCR2 receptor antagonists for treating inflammatory bowel diseases, such as Crohn¢â‚¬â„¢s disease and ulcerative colitis. Furthermore, several clinical trials are ongoing to assess the potential use of chemokine receptors as a therapeutic tool for various inflammatory conditions, including rheumatoid arthritis and psoriasis.
Cancer is another major application area where these reagents find numerous applications across different tumor types. For instance, MCC-54301 (SARamponavir) is an anti-retroviral agent that targets chemokine receptors for cancer treatment; it has shown promising results against various solid tumors in preclinical studies.
Regional Analysis:
North America dominated the global CXCR1 market in 2017. The region is expected to maintain its dominance over the forecast period as well due to increasing research and development activities by various companies. For instance, in May 2018, Pfizer Inc., a U.S.-based pharmaceutical company announced that it would be discontinuing trials of its new drug application for patients with advanced lung cancer because of safety concerns raised by data from earlier trials involving this drug combination.
Growth Factors:
- Increasing incidence of cancer
- Growing demand for targeted therapies
- Rising prevalence of chronic diseases
- Technological advancements in the field of oncology
- increasing awareness about CXCR1 inhibitors
Scope Of The Report
Report Attributes
Report Details
Report Title
C-X-C Chemokine Receptor Type 1 Market Research Report
By Type
DF-2755A, PAC-G31P, Reparixin, SX-576, Others
By Application
Inflammation, Lung Cancer, Melanoma, Post-Operative Pain, Others
By Companies
Dompe Farmaceutici SpA, Syntrix Biosystems Inc, Vaccibody AS
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
187
Number of Tables & Figures
131
Customization Available
Yes, the report can be customized as per your need.
Global C-X-C Chemokine Receptor Type 1 Market Report Segments:
The global C-X-C Chemokine Receptor Type 1 market is segmented on the basis of:
Types
DF-2755A, PAC-G31P, Reparixin, SX-576, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Inflammation, Lung Cancer, Melanoma, Post-Operative Pain, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Dompe Farmaceutici SpA
- Syntrix Biosystems Inc
- Vaccibody AS
Highlights of The C-X-C Chemokine Receptor Type 1 Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- DF-2755A
- PAC-G31P
- Reparixin
- SX-576
- Others
- By Application:
- Inflammation
- Lung Cancer
- Melanoma
- Post-Operative Pain
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the C-X-C Chemokine Receptor Type 1 Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
C-X-C chemokine receptor type 1 is a protein that binds to the C-X-C motifs in chemokines, which are small proteins that regulate inflammation and cell migration.
Some of the major companies in the c-x-c chemokine receptor type 1 market are Dompe Farmaceutici SpA, Syntrix Biosystems Inc, Vaccibody AS.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 C-X-C Chemokine Receptor Type 1 Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 C-X-C Chemokine Receptor Type 1 Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 C-X-C Chemokine Receptor Type 1 Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the C-X-C Chemokine Receptor Type 1 Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global C-X-C Chemokine Receptor Type 1 Market Size & Forecast, 2020-2028
4.5.1 C-X-C Chemokine Receptor Type 1 Market Size and Y-o-Y Growth
4.5.2 C-X-C Chemokine Receptor Type 1 Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 DF-2755A
5.2.2 PAC-G31P
5.2.3 Reparixin
5.2.4 SX-576
5.2.5 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Inflammation
6.2.2 Lung Cancer
6.2.3 Melanoma
6.2.4 Post-Operative Pain
6.2.5 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global C-X-C Chemokine Receptor Type 1 Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 C-X-C Chemokine Receptor Type 1 Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 DF-2755A
9.6.2 PAC-G31P
9.6.3 Reparixin
9.6.4 SX-576
9.6.5 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Inflammation
9.10.2 Lung Cancer
9.10.3 Melanoma
9.10.4 Post-Operative Pain
9.10.5 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 DF-2755A
10.6.2 PAC-G31P
10.6.3 Reparixin
10.6.4 SX-576
10.6.5 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Inflammation
10.10.2 Lung Cancer
10.10.3 Melanoma
10.10.4 Post-Operative Pain
10.10.5 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 DF-2755A
11.6.2 PAC-G31P
11.6.3 Reparixin
11.6.4 SX-576
11.6.5 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Inflammation
11.10.2 Lung Cancer
11.10.3 Melanoma
11.10.4 Post-Operative Pain
11.10.5 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 DF-2755A
12.6.2 PAC-G31P
12.6.3 Reparixin
12.6.4 SX-576
12.6.5 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Inflammation
12.10.2 Lung Cancer
12.10.3 Melanoma
12.10.4 Post-Operative Pain
12.10.5 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 DF-2755A
13.6.2 PAC-G31P
13.6.3 Reparixin
13.6.4 SX-576
13.6.5 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Inflammation
13.10.2 Lung Cancer
13.10.3 Melanoma
13.10.4 Post-Operative Pain
13.10.5 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 C-X-C Chemokine Receptor Type 1 Market: Competitive Dashboard
14.2 Global C-X-C Chemokine Receptor Type 1 Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Dompe Farmaceutici SpA
14.3.2 Syntrix Biosystems Inc
14.3.3 Vaccibody AS
